In Genentech's latest Ocrevus campaign, real patients signal their use of the twice-yearly med and new symbol of community.

Peace out: Roche’s Genen­tech adopts V hand sig­nal in next-gen Ocre­vus cam­paign for mul­ti­ple scle­ro­sis

The two-fin­ger V sign de­buted in Roche’s Genen­tech first TV com­mer­cial for mul­ti­ple scle­ro­sis treat­ment Ocre­vus. Re­al pa­tients star­ring in the “Dear MS” launch ads …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.